Abstract-The intracerebroventricular administration of salmon calcitonin (sCT) to rats induced a dose-dependent increase in the number of head twitches and poten tiated such a response elicited by L-5-hydroxytryptophan (L-5-HTP). Subcu taneously administered sCT was ineffective "per se" but could again potentiate the head twitch response elicited by L-5-HTP.
Abstract-The intracerebroventricular administration of salmon calcitonin (sCT) to rats induced a dose-dependent increase in the number of head twitches and poten tiated such a response elicited by L-5-hydroxytryptophan (L-5-HTP). Subcu taneously administered sCT was ineffective "per se" but could again potentiate the head twitch response elicited by L-5-HTP.
Since these data suggest a stimulation of the brain serotonergic pathways, the obtained results support the hypothesis that some central actions of sCT may involve activation of serotonergic systems in the rat brain.
should enhance this increase. Head twitches were chosen as they are a quantifiable and reliable measure of serotonergic activation: the response is dose-related and appears even in the presence of low doses of 5-HT agonists (4) . Male Sprague Dawley rats (Nossan, Milano, Italy) weighing 250-300 g were used. They were housed under con trolled conditions of light (7.00 a.m.-7.00 p.m.), temperature (22+2°C) and humidity (65%) and were allowed free access to standard laboratory diet and tap water. sCT was kindly supplied by Sandoz (Basel) as commercial vials (containing 100 MRCU=20 ug of peptide, 2 mg of acetic acid, 2 mg of sodium acetate, 7.5 mg of sodium chloride and distilled water to 1 ml volume) and as pure powder. As needed, these vials were diluted with saline, and sCT was s.c. injected at the doses of 5, 10, 20, 40 and 80 /ig/kg; control rats received 4 ml/kg of saline containing ace tic acid. I.c.v. injected rats were implanted, at least 7 days before the behavioral trials, with permanent plastic cannulae entering the right ventricle. By this route, the powder form of sCT dissolved in sterile saline containing 0.5% human albumin was administered at the doses of 0.1, 0.2, 0.4 and 0.8 ug/rat; control animals received only vehicle (20 al/rat). Immediately after treatment, the rats were put into transparent plexiglas cylinders (20 cm diameter, 25 cm height), and 30 min later, the head-twitches exhibited by the animals were counted for 60 min by an experienced observer unaware of the treatments. The obtained data were submitted to linear regression analysis. As far as effect on head twitch response to L-5-HTP, the rats were pretreated with sCT either s. . After an additional thirty min, the rats were s.c. injected with different doses (see Table 1 ) of L-5-HTP (Sigma, St. Louis, U.S.A.) dissolved in saline containing a few drops of HCI 0.1 N. The head twitch responses were counted for 90 min starting 15 min after the L-5-HTP injection. Statistical analysis was performed by means of two-way factorial ANOVA (sCTX L-5-HTP). Since a significant "'sCTX L -5-HTP doses" interaction was obtained, saline pretreated groups were compared to the respective sCT pretreated groups within each level of the factor "L-5 HTP dose". Fig. 1 . Relationship between the log-dose of sCT and the number of head twitches. Values are ex pressed as the mean±S.E.M. (in brackets, the number of rats). In the reported range, the response was linearly related to the log-dose of sCT (r=0.910, P<0.01 ).
The s.c. or i.c.v. administered sCT did not produce excitation, depression or other non specific effects on the rat behavior. On the other hand, the administered doses were high enough to reduce both food and water intake (5). Moreover, most of the i.c.v. treated rats exhibited ,"tail whipping", as already des cribed (6). All these effects were not evaluated. Figure 1 shows 2 fig/rat ), did not induce "per se" head twitch behavior. Therefore the s.c. administration of sCT produced effects similar to those induced by i.c.v. injection but less marked. To explain this discrepancy, we could hypothesize that sCT effects on head twitch behavior are mediated by a direct (more effective) or an indirect (less effective) inhibition of the Ca2+ neuronal influx that, in turn, activates the brain serotonergic systems. In fact, it has been found (7) that sCT inhibits in vitro Ca2+ uptake by hypothalamic neurons. This dose dependent (8) action can be exerted by the i.c.v. but not the s.c. given peptide; on the contrary, s.c. given sCT could operate only by means of a marked and long-lasting hypocalcaemia.
This hypocalcaemia might have caused modification of the Ca2+ in the brain resulting in an increased release of 5 HT, especially when the neuronal store of the neurotransmitter was increased owing to L-5-HTP administration.
In this regard, it is likely that, besides the serotonergic system, many other neuronal systems should be influenced by hypocalcaemia and play a role in the sCT-induced headtwitch behavior.
It has been reported (6) that i.c.v. admin istered sCT also produces hypocalcaemia. Nevertheless, taken together, the obtained findings agree with the suggestion concern ing the involvement of brain serotonergic pathways in some central actions of calci tonins. In fact, it has been reported that a) the anorectic effect of sCT is strictly related to its ability to activate the serotonergic hypothalamic system (3), b) the analgesic activity of sCT involves a central serotonergic mechanism (9) , and c) the stimulation of rat brain acetylcholinesterase activity induced by the porcine calcitonin is mediated by serotonin (10) .
In conclusion, the present findings further support the hypothesis that sCT administered either subcutaneously or intracerebroven tricularly is able to activate brain serotonergic systems in the rat.
